Effect of interferon-alpha treatment in hemodialysis patients and renal transplant recipients with chronic hepatitis C

By Tokumoto T.   Tanabe K.   Ishikawa N.   Simizu T.   Oshima T.   Noguchi S.   Gouya N.   Nakazawa H.   Hashimoto E.   Fuchinoue S.   Hayashi N.   Toma H.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 2887-2889

Elsevier

Access to resources Recommend Favorite

Outcome of kidney transplant in chronic hepatitis C virus patients: effect of pretransplantation Interferon-Alpha 2b monotherapy

By Gonzalez-Roncero F.   Gentil M.A.   Valdivia M.A.   Algarra G.   Pereira P.   Toro J.   Sayago M.   Mateos J.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1745-1747

Elsevier

Access to resources Recommend Favorite

Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer - investigation of dose level with clinical correlates

By Burns L.J.   Weisdorf D.J.   DeFor T.E.   Repka T.L.   Ogle K.M.   Hummer C.   Miller J.S.  

Experimental Hematology, Vol. 28, Iss. 1, 2000-01 ,pp. : 96-103

Elsevier

Access to resources Recommend Favorite

Tumor with features of renal cell carcinoma and of transitional cell carcinoma

By Beckman Edwin  

Virchows Archiv, Vol. 444, Iss. 5, 2004-05 ,pp. : 465-465

Springer Publishing Company

Access to resources Recommend Favorite

Indirect comparisons of efficacy and safety between seven newer targeted agents for metastatic renal cell carcinoma: A network metaanalysis of randomised clinical trials

By      

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 858-864

Spandidos Publications

Access to resources Recommend Favorite